Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc > OH, It sound really awful ; - )

<< Previous

Bullboard Posts

Next >>

Post by SouthernTierTomon Jan 18, 2021 9:28am

235 Views

Post# 32318664

OH, It sound really awful ; - )

I was looking at Pennispincher's history and noticed he had signed up 5 years before his first post....you know what that means right??

TROUBLE - "nefarious bullboard activity"..AKA Beech Boy infestation...

I'm interested in Cipher, loe float, actual earnings and a previous move to $20....hmmmm ; - )

The current piece of news has impact on revenue.......BUT the bullbored effort appears to be looking to get A LOT of milaeage from the "event"

Is this another Canada / Korea ASP -like event?

I smell D R A M A - I smell the "Beech"

GLTA

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec